Two ResMed Board Members Named “2018 Most Influential Corporate Directors” by WomenInc. Magazine
ResMed directors Carol J. Burt and Karen Drexler recognized as female leaders helping shape the future of America’s top companies

SAN DIEGO – November 20, 2018 – ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced that two of its board members, Carol J. Burt and Karen Drexler have been named to WomenInc. Magazine’s list of “2018 Most Influential Corporate Directors,” a list of women executives, influencers and achievers contributing leadership to corporate boards.

Burt has served on ResMed’s board since November 2013, is chair of its Audit Committee, and is principal of Burt-Hilliard Investments. She has more than 35 years of executive management experience in the healthcare, health insurance and financial service industries. Drexler has been a ResMed board director and Compensation Committee member since November 2017 and is CEO of Sandstone Diagnostics, Inc., a medical testing consumables company. Her executive management experience spans medical technology, data security, and out-of-hospital care models. Both have served on multiple boards in addition to ResMed’s.

“It is essential that the achievements and success of professional women are showcased in the highest regard and their stories are told in meaningful ways,” said Catrina Young, Executive Vice President and Chief Communications Officer of WomenInc. Magazine. “We are inspired by these accomplished executives, their distinguished careers and the corporations that demonstrate inclusive board composition.”

“We’re honored to be listed among so many successful, innovative women driving businesses and the products and services they provide,” said Burt and Drexler in a joint statement. “Diversity at the board level and in the workplace contributes unique perspectives that help support the companies and communities they serve. We’re proud to serve on the board of ResMed, the world’s leading software-driven medical device company, which is built upon the great ideas and relentless work of its diverse team of more than 6,000 ResMedians worldwide.”

Read Carol’s and Karen’s full bios here.

See all of WomensInc. Magazine’s “2018 Most Influential Corporate Directors” in its winter 2019 issue, available today at newsstands and Barnes & Noble bookstores.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

# # #

MEDIA: Jayme Rubenstein, 858.836.6798, news@resmed.com | INVESTORS: Amy Wakeham, 858.836.5000, investorrelations@resmed.com
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages